1Ferriero DM. Neonatal brain injury[J]. N Eng J Med, 2004(351): 1985-1995.
2Erbayraktar S, Yilrnaz O, Gokmen N, et al. Erythropoietin is a muhifunetional tissue-protective cytokine[J]. Curr Hematol Rep, 2003, 2(6): 465-470.
3Ehrenreich H, Aust C, Krampe H, et al. Erythropoietin: novel approaches to neuroprotection in human brain disease[J]. Metab Brain Dis, 2004, 19(3-4): 195-206.
4Thompson CM, Puterman AS, Linley LL, et al. The value of a scoring system for hypoxic-ischaemic encephalopathy in predicting neurodevelopmental outcome[J]. Acta Pediatr,1997(86): 757-761.
5Bao XL, Yu RJ, Li ZS, et al. Twenty - item behavioral neuro- logical assessment for normal newborns in 12 cities of China [J]. Chin Med J(Engl), 1991(9): 742-746.
7Li F, Chong ZZ, Maiese K. Erythropoietin on a tightrope: Balan- cing neuronal and vascular protection between intrinsic and extrinsic pathways[J]. N eurosignals, 2004, 13(6): 265-289.
8Brines ML, Ghezzi P, Keenan S, et al. Erythropoietin crosses the blood brain barrier to protect against experimental brain injury[JJ. Proc Natl Acad Sci USA, 2000, 97(19): 1052-1053.
2Brines ML, Ghezzi P, Keenan S, et al. Erythropoietin crosses the blood- brain barrier to protect against experimental brain injury[J ].Proc Natl Acad Sci USA, 2000,97( 19):10526- 10531.
3Neumann D, Yuk MH, Lodish HF, et al. Blocking intracellular intracellular degradation of the erythropoietin and asialoglycoprotein receptors by calpain inhibitors does not result in the memberane and secreted forms [J ]. Biochem J, 1996,313: 391 - 399.
4Grasso G, Buemi M, Alafaci C, et al. Beneficial effects of systemic administration of recombinant human erythropoetin in rabbits subjected to subarachnoid hemorrhage[J ]. Proc Natl Acad Sci USA,2002,99: 5627 - 5631.
5Martinez- Estrada OM, Rodriguez- Millan E, de Vicente EG, et al. Erythropoietin protects the in vitro blood- brain barrier against VEGF- induced permeability [J ]. Eur J Neuroc, 2003,18: 2538 -2544.
6Juul SE, McPherson RJ, Farrell FX, et al. Erythropoietin concentrations in cerebrospinal fluid of nonhuman primates and fetal sheep following high - dose recombinant erythropoietin [J ]. Biol Neonate,2004,85:138 - 144.
7Springborg JB, Ma X, Rochat P, et al. A single subcutaneous bolus of erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid haemorrhage in rats [J ]. Br J Pharmacol,2002,135:823 - 829.
8Kumral A, Ozer E, Yilmaz O, et al. Neuroprotective effect of erythropoietin on hypoxic - ischemic brain injury in neonatalrats [J ].Biol Neonate, 2003,83: 224 - 228.
9Eid T, Brines M. Recombinant human erythropoetin for neuroprotection: What is the evidence[J ]. Clin Breast Cancer Suppl, 2002,3(3):109- 115.
10Ferriero DM. Neonatal brain injury[J]. N Eng J Med, 2004, 351:1985-1995.
9BrinesML, Ghezzi P, Keenan S, et al. Erythropoietin cros- ses the blood brain barrier to protect against experimental brain injury[J]. Proc Natl Acad Sci USA, 2000,97(19): 10526-10531.
